Vol 3, No 2 (2000)
Brief communication
Published online: 2003-05-27
Page views 555
Article views/downloads 0
Get Citation

Connect on Social Media

Connect on Social Media

Recombinant human TSH for the treatment of differentiated thyroid cancer metastatic to the spine

Barbara Jarząb, Józef Roskosz, Marzena Gawkowska-Suwińska, Maria Turska, Daria Handkiewicz-Junak, Zbigniew Puch, Zbigniew Wygoda, Aleksander Zajusz
Nucl. Med. Rev 2000;3(2):157-160.


The diagnostic use of recombinant human TSH (rhTSH) in follow- up of differentiated thyroid cancer (DTC) is already approved, however its application in 131I therapy is still to be evaluated. We report results obtained in four patients with DTC metastatic to central skeleton, in whom 5 courses of rtTSH aided 131I therapy were administered.